Wells initiates Pfizer at overweight, says Covid treatments are here to stay
[ad_1]
A girl holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in entrance of displayed Pfizer emblem on this illustration taken, October 30, 2020.
Dado Ruvic | Reuters
Pfizer is poised to outperform as its Covid remedies stick round and generate main income for the corporate, in keeping with Wells Fargo.
[ad_2]